StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Regeneron Pharma (REGN) Cocktail EUA Widely Expected - Credit Suisse
November 23, 2020 7:19 AM
Credit Suisse analyst Evan Seigerman reiterated an Outperform rating and $737.00 price target on Regeneron Pharma (NASDAQ: REGN) after the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments